SEC Form 17-A (Annual Report)
SEC Form 17-Q (Quarterly Report)
-
- 2024
– 17Q ending March 31 2024 - 2023
– 17Q ending March 31 2023
– 17Q ending June 30, 2023
– 17Q ending September 30, 2023 - 2022
– 17Q ending March 31 2022
– 17Q ending June 30 2022
– 17Q ending September 30 2022 - 2021
– 17Q ending September 30 2021
– 17Q ending June 30, 2021
– 17Q ending March 31, 2021 - 2020
– For quarter ending 30 September 2020
– For quarter ending 30 June 2020
– For quarter ending 30 March 2020 - 2019
– For quarter ending 30 September 2019
– For quarter ending 30 June 2019
– For quarter ending 31 March 2019 - 2018
– For quarter ending 30 September 2018
– For quarter ending 30 June 2018
– For quarter ending 31 March 2018 - 2017
– 17Q ending 30 Sept. 2017
– For quarter ending 30 June 2017
– For the quarter ending 31 March 2017 - 2016
– For the quarter ending 31 March 2016– For the quarter June 30, 2016– For the quarter September 30, 2016 - 2015
– For quarter ending 31 March 2015– For quarter ending 30 June 2015– For quarter ending 30 September 2015 - 2014
– For quarter ending 31 March 2014
– For the period 30 June 2014
– For the period 30 September 2014 - 2013
– For quarter ending 31 March 2013
–
- 2023
–
- 2024
SEC Form 17-C
-
- 2024
– Ratification of CBA
– Results of 2024 Annual Stockholders’ Meeting and Organizational Meeting
– Amendment of Company By-Laws
– Board Approvals – ASM 2024, Issuance of AFS, Nominees for Election of Board of Directors
– Certifications of Independent Directors
- 2023
– Results of Annual Stockholders’ and Organizational Meeting, 21 June 2023
– List of Stockholders as of Record
– Annual Stockholders’ Meeting, Issuance of Audited Financial Statement & Nominees for Election as Members of the Board 2023-2024
– Certification of Independent Directors
– Amendment to Declaration of Cash
– Declaration of Cash Dividend - 2022
– Board Approvals, 29 March 2022
– List of Stockholders, 16 May 2022
– Results of Euro-Med Annual Stockholders’ Meeting and Organizational Meeting
– Certificates of Participation for the Annual Corporate Governance Seminar
– Declaration of Cash Dividend
– Appointment of New External Auditor - 2022
– Board of Directors Attendance and Compliance Certificate
– Various Board Approval, March 30, 2021
– Certification of Independent Directors
– Demise of a Director
– Nomination of Anthony Joseph Y. Gaw as Member of the Board of Directors
– List of Stockholders
– Results of Annual Stockholders’ Meeting and Organizational Meeting
– Attendees Corporate Governance Training
– Declaration of Cash Dividend
–
- 2024
20-IS Definitive Information Statement:
- For year 2024
- For year 2023
- For year 2022
- For year 2021
- For year 2020
- For year 2019
- For year 2018
- For year 2017
- For year 2016
- For year 2015
General Information Statement:
- For year 2023
- For year 2022
- For year 2021
- For year 2020
- For year 2019
- For year 2018
- For year 2017
- For year 2016
- For year 2015
23-A/B Statement of Beneficial Ownership:
- 2022
– 23-B for Mr. Enrique Raymond I. Yap (indirect shares)
– 23-B for Mr. Enrique Y. Yap, Jr. (indirect shares)
– 23-B for Mr. Johnny C. Yap (indirect shares)
– 23-A Initial Statement of Beneficial Owner Anthony Joseph Y. Gaw
– 23-B for Mr. Basilio C. Yap (indirect shares)
– 23-B for Mr. Benjamin C. Yap (indirect shares)
- 2020
– 23-B MVYY January 08, 2020
– 23-B MVYY March 3, 2020
– 23-B MVYY March 2, 2020
– 23-B MVYY March 4, 2020
– Amended 23-A 23-A EYY, Jr. August 2020
- 2018
– SEC 23-B MVYY Jan. 08, 2018
– SEC 23-B MVYY Feb. 23, 2018
– SEC 23-B MVYY Mar. 2, 2018
– SEC 23-B MVYY April 12, 2018
– SEC Form 23-B MVYY April 02, 2018
– SEC Form 23-B M.Yap Jan. 26, 2018
– SEC 23-B MVYY Mar. 21, 2018
– SEC 23-B MVYY May 22, 2018
– SEC 23-B MVYY May 25, 2018
– SEC Form 23-B MVYY April 02, 2018
– SEC Form 23-B MVYY July 11, 2018
– SEC Form 23-B MVYY Oct. 11, 2018
– SEC Form 23-B MVYY Oct. 12, 2018
- 2022